<VariationArchive VariationID="2579269" VariationName="GRCh38/hg38 5q13.3(chr5:74695284-74702264)x0" VariationType="copy number loss" Accession="VCV002579269" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2023-09-16" MostRecentSubmission="2023-09-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2744307" VariationID="2579269">
      <GeneList>
        <Gene Symbol="HEXB" FullName="hexosaminidase subunit beta" GeneID="3074" HGNC_ID="HGNC:4879" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="74640023" stop="74721288" display_start="74640023" display_stop="74721288" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="73980968" stop="74017112" display_start="73980968" display_stop="74017112" Strand="+" />
          </Location>
          <OMIM>606873</OMIM>
        </Gene>
      </GeneList>
      <Name>GRCh38/hg38 5q13.3(chr5:74695284-74702264)x0</Name>
      <VariantType>copy number loss</VariantType>
      <Location>
        <CytogeneticLocation>5q13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="74695284" stop="74702264" display_start="74695284" display_stop="74702264" variantLength="6981" />
      </Location>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="GRCh38/hg38 5q13.3(chr5:74695284-74702264)x0 AND Sandhoff disease" Accession="RCV003327708" Version="3">
        <ClassifiedConditionList TraitSetID="1058">
          <ClassifiedCondition DB="MedGen" ID="C0036161">Sandhoff disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-09-16" MostRecentSubmission="2023-09-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">28476546</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31690835</ID>
          <ID Source="pmc">7313390</ID>
          <ID Source="DOI">10.1038/s41436-019-0686-8</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1058" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4366" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Beta-hexosaminidase-beta-subunit deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GM2 gangliosidosis, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Total hexosaminidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hexosaminidase A and B deficiency Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sandhoff-Jatzkewitz-Pilz disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GM2-GANGLIOSIDOSIS, TYPE II</ElementValue>
                <XRef Type="MIM" ID="268800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HEXOSAMINIDASES A AND B DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="268800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Sandhoff disease</ElementValue>
                <XRef ID="Sandhoff+disease/6408" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010006" DB="MONDO" />
                <XRef ID="23849003" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Sandhoff disease comprises a phenotypic continuum encompassing acute infantile, subacute juvenile, and late-onset disease. Although classification into these phenotypes is somewhat arbitrary, it is helpful in understanding the variation observed in the timing of disease onset, presenting manifestations, rate of progression, and life span. Acute infantile Sandhoff disease (onset age &lt;6 months). Infants are generally normal at birth followed by progressive weakness and slowing of developmental progress, then developmental regression and severe neurologic impairment. Seizures are common. Death usually occurs between ages two and three years. Subacute juvenile Sandhoff disease (onset age 2-5 years). After attaining normal developmental milestones, developmental progress slows, followed by developmental regression and neurologic impairment (abnormal gait, dysarthria, and cognitive decline). Death (usually from aspiration) typically occurs in the early to late teens. Late-onset Sandhoff disease (onset older teen years or young adulthood). Nearly normal psychomotor development is followed by a range of neurologic findings (e.g., weakness, spasticity, dysarthria, and deficits in cerebellar function) and psychiatric findings (e.g., deficits in executive function and memory). Life expectancy is not necessarily decreased.</Attribute>
                <XRef ID="NBK579484" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2521" />
                <XRef ID="2521" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">35420740</ID>
                <ID Source="BookShelf">NBK579484</ID>
              </Citation>
              <XRef ID="796" DB="Orphanet" />
              <XRef ID="C0036161" DB="MedGen" />
              <XRef ID="MONDO:0010006" DB="MONDO" />
              <XRef Type="MIM" ID="268800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7549778" SubmissionDate="2023-09-11" DateLastUpdated="2023-09-16" DateCreated="2023-09-16">
        <ClinVarSubmissionID localKey="5483|OMIM:268800|copy:0|refcopy:2" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004034166" DateUpdated="2023-09-16" DateCreated="2023-09-16" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31690835</ID>
          </Citation>
          <Comment>A homozygous deletion of exons 4-5 in HEXB (NM_000521.4) was identified by exome sequencing and confirmed by genome sequencing in one individual with Sandhoff disease ([GRCh 38] chr5:74695284_74702264x0). Inheritance information is unavailable. The patient phenotype is nonspecific, but is consistent with cases described in the literature and/or published databases with overlapping variants. This exon deletion has also been reported in the literature, in the compound heterozygous state, in one individual with Sandhoff disease (PMID: 28476546; Variation ID: 644276). This intragenic variant is predicted to cause a frameshift, which alters the proteinâ€™s amino acid sequence beginning at exon 4 and leads to a premature termination codon. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of HEXB is an established disease mechanism in autosomal recessive Sandhoff disease. A slightly larger overlapping deletion has been identified in 0.03% (2/7624) of European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; Structural variant: DEL_5_59086). Although a deletion overlapping the region of this CNV has been seen in the general population in a heterozygous state, its frequency is not high enough to rule out a pathogenic role. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Sandhoff disease. The ACMG/ClinGen evidence codes and points used in this curation are as follows: 1: 0 points, 2: 0.9 points, 3: 0 points, 4-5: 0.23 points; Total: 1.13 points; Riggs 2020 (PMID: 31690835).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG/ClinGen CNV Guidelines, 2019</Attribute>
          <Citation>
            <ID Source="PubMed">31690835</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <Citation>
              <ID Source="PubMed">28476546</ID>
            </Citation>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HEXB" />
          </GeneList>
          <VariantType>copy number loss</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="5" start="74695284" stop="74702264" variantLength="6981" />
          </Location>
          <AttributeSet>
            <Attribute Type="AbsoluteCopyNumber">0</Attribute>
          </AttributeSet>
          <AttributeSet>
            <Attribute Type="ReferenceCopyNumber">2</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="268800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13816677</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7549778" TraitType="Disease" MappingType="XRef" MappingValue="268800" MappingRef="OMIM">
        <MedGen CUI="C0036161" Name="Sandhoff disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

